☆ 4.6 Letter

Canagliflozin Improves the Recovery of Blood Flow in an Experimental Model of Severe Limb Ischemia

JACC-BASIC TO TRANSLATIONAL SCIENCE (2018)

Get Full Text
Add to Collection

Journal

JACC-BASIC TO TRANSLATIONAL SCIENCE
Volume 3, Issue 2, Pages 327-329

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jacbts.2018.01.010

Keywords

-

Categories

Cardiac & Cardiovascular Systems

Funding

  1. Amgen
  2. AstraZeneca
  3. Boehringer Ingelheim
  4. Janssen
  5. Servier
  6. Merck
  7. Eli Lilly
  8. Amarin
  9. Bristol-Myers Squibb
  10. Chiesi
  11. Eisai
  12. Ethicon
  13. Forest Laboratories
  14. Ironwood
  15. Ischemix
  16. Lilly
  17. Medtronic
  18. Pfizer
  19. Roche
  20. Sanofi-Aventis
  21. The Medicines Company

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.